Slide background
Slide background




Factsheet for Manufacturers of Medical Devices and In-Vitro Diagnostic

ID 7854 | | Visite: 2329 | Documenti Marcatura CE UEPermalink: https://www.certifico.com/id/7854

Factsheet for Manifacturers of Medical Devices   In Vitro Diagnostic

Factsheet for Manufacturers of Medical Devices and In-Vitro Diagnostic

1. Factsheet for Manufacturers of Medical Devices
2. Factsheet for Manufacturers of In-Vitro Diagnostic Medical Devices

Medical Devices Regulation (2017/745/EU)

The new Medical Devices Regulation (2017/745/EU) (MDR) and the In-Vitro Diagnostic Medical Regulation (2017/746/EU) (IVDR) bring EU legislation into line with technical advances, changes in medical science, and progress in law making. The new Regulations will create a robust, transparent, and sustainable regulatory framework, recognised internationally, that improves clinical safety and creates fair market access for manufacturers. In contrast to Directives, Regulations do not need to be transposed into national law. The MDR and the IVDR will therefore reduce the risks of discrepancies in interpretation across the EU market. Transitional periods are planned to smooth the application of the new Regulations. However, you should bear in mind that consultants, in-house professionals, and Notified Bodies will all get busier as the deadline draws closer.

Medical Devices Regulation (MDR) background The MDR will replace the existing Medical Devices Directive (93/42/EEC) (MDD) and the Active Implantable Medical Devices Directive (90/385/EEC) (AIMDD). The MDR was published in May 2017, marking the start of a three-year period of transition from the MDD and the AIMDD. During the transitional period the MDR will come into force gradually, starting with the provisions related to the designation of Notified Bodies and the ability of manufacturers to apply for new certificates under the MDR. The transitional period will end on 26 May 2020, the “Date of Application” (DoA) of the Regulation. From that date the MDR will apply fully.

To avoid market disruption and allow a smooth transition from the Directives to the Regulation, several transitional provisions are in place (Article 120). Some devices with certificates issued under the Directives (AIMDD/MDD certificates) may continue to be placed on the market until 27 May 2024 , and made available until 27 May 2025. During the transition phase, products certified under the Directives and products certified under the Regulation will coexist on the market. Both will have equal status under the law, and no discrimination in public tenders may take place.

In-Vitro Diagnostic Medical Regulation (2017/746/EU)

The IVDR will replace the existing In-Vitro Diagnostic Medical Devices Directive (98/79/EC) (IVDD). The IVDR was published in May 2017, marking the start of a five-year period of transition from the IVDD.

During the transitional period the IVDR will come into force gradually, starting with the provisions related to the designation of Notified Bodies and the ability of manufacturers to apply for new certificates under the IVDR.

The transitional period will end on 26 May 2022, the “Date of Application” (DoA) of the Regulation. From that point the IVDR will apply fully.

To avoid market disruption and allow a smooth transition from the Directive to the Regulation, several transitional provisions are in place (Article 110). During the transition phase, products certified under the Directive and products certified under the Regulation will coexist on the market. Both will have equal status under the law, and no discrimination in public tenders may take place.

EC 2018

Tags: Marcatura CE Abbonati Marcatura CE Regolamento Dispositivi Medici Regolamento DMD Vitro

Ultimi archiviati Marcatura CE

Decisione di esecuzione UE 2023 1096
Giu 06, 2023 21

Decisione di esecuzione (UE) 2023/1096

Decisione di esecuzione (UE) 2023/1096 / Incidenti connessi all'uso di articoli pirotecnici ID 19749 | 06.06.2023 Decisione di esecuzione (UE) 2023/1096 della Commissione del 2 giugno 2023 recante modalità di applicazione della direttiva 2013/29/UE del Parlamento europeo e del Consiglio per quanto… Leggi tutto
Mag 24, 2023 81

Regolamento delegato (UE) 2023/807

Regolamento delegato (UE) 2023/807 ID 19674 | 24.05.2023 Regolamento delegato (UE) 2023/807 della Commissione del 15 dicembre 2022 che rivede il fattore di energia primaria per l’energia elettrica in applicazione della direttiva 2012/27/UE del Parlamento europeo e del Consiglio GU L 101/16 del… Leggi tutto
Decisione di esecuzione  UE  2023 975
Mag 17, 2023 125

Decisione di esecuzione (UE) 2023/975

in RAPEX
Decisione di esecuzione (UE) 2023/975 / Modifiche Linee guida RAPEX ID 19640 | 17.05.2023 Decisione di esecuzione (UE) 2023/975 della Commissione del 15 maggio 2023 che modifica la decisione di esecuzione (UE) 2019/417 della Commissione recante linee guida per la gestione del sistema d’informazione… Leggi tutto

Più letti Marcatura CE